ArticleScientific reports2019

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma.

Kenichiro Enooku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.